Homocysteine Concentrations and Molecular Analysis in Patients with Congenital Heart Defects

Archives of Medical Research

Volumn 38, Issue 2, 2007, Pages 212-218

  Galdieri, Luciano C ^a   Arrieta, Santiago R ^b   Silva, Célia M C ^a   Pedra, Carlos A C ^b   D'Almeida, Vânia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Congenital heart defects; Cystathionine synthase; Folic acid; Homocysteine; Methionine synthase; Methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MOTHER; VITAMIN BLOOD LEVEL;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; ALLELES; CARBON-NITROGEN LIGASES; CHILD, PRESCHOOL; CYSTATHIONINE BETA-SYNTHASE; FEMALE; FOLIC ACID; GENE FREQUENCY; HEART DEFECTS, CONGENITAL; HOMOCYSTEINE; HUMANS; MALE; MUTATION; VITAMIN B 12;

EID: 33846177202     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.09.012     Document Type: Article

References (37)

1. Perez A.B., D'Almeida V., Vergani N., de Oliveira A.C., de Lima F.T., and Brunoni D. Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet 119A (2003) 20-25
2. Wenstrom K.D., Joahnning G.L., Owen J., Johnston K.E., Acton S., Cliver S., et al. Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrofolate reductase genotypes, and neural tube closure sites. Am J Med Genet 90 (2000) 6-11
3. Nygard O., Vollset S.E., Refsum H., Brattstrom L., and Ueland P.M. Total homocysteine and cardiovascular disease. J Int Med 246 (1999) 425-454
4. Itikala P.R., Watkins M.L., Mulinare J., Moore C.A., and Liu Y. Maternal multivitamin use and orofacial clefts in offspring. Teratology 63 (2001) 79-86
5. Kapusta L., Haagman M.L.M., Steegers E.A.P., Cuyoers M.H.M., Blom H.J., and Eskes T.K.A.B. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 135 (1999) 773-774
6. Wenstrom K.D., Joahnning G.L., Johnston K.E., and DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 184 (2001) 806-817
7. Goldmuntz E. The epidemiology and genetics of congenital heart disease. Clin Perinatol 28 (2001) 1-10
8. Botto L.D., Mulinare J., and Erickson J.D. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 151 (2000) 878-884
9. Rittler M., Liascivich R., Lopez-Camelo J., and Castilla E.E. Parental consanguinity in specific types of congenital anomalies. Am J Med Genet 102 (2001) 36-43
10. Guitti J.C.S. Epidemiological characteristics of congenital heart diseases in Londrina, Paraná South Brazil. Arqu Bras Cardiol 74 (2000) 400-404
11. Rosenquist T.H., Ratashak A.S., and Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci 93 (1996) 15227-15232
12. Czeizel A.E., and Dudás I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327 (1992) 1832-1835
13. Shaw G.M., O'Malley C.D., Wasserman C.R., Tolarova M.M., and Lammer E.J. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59 (1995) 536-545
14. Botto L.D., Khoury M.J., Mulinare J., and Erickson J.D. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 98 (1996) 911-916
15. Czeizel A.E. Reductions of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62 (1996) 179-183
16. Tierney B.J., Ho T., Reedy M.V., and Brauer P.R. Homocysteine inhibits cardiac neural crest cell formation and morphogenesis in vivo. Dev Dyn 1 (2004) 63-73
17. Mills J.L., McPartlin J.M., Kirke P.N., Lee Y.J., Conley M.R., Weir D.G., et al. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345 (1995) 149-151
18. Leclerc D., Odièvre M.H., Wu Q., Wilson A., Huizenga J.J., Rozen R., et al. Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. Gene 240 (1999) 75-88
19. Volcik K.A., Shaw G.M., Lammer E.J., Zhu H., and Finnell R.H. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low spina bifida defects. Birth Defects Res Clin Mol Teratol 67 (2003) 154-157
20. Dooling M.T., Barbaux S., McDonnell M., Hoess K., Whitehead A.S., and Mitchell L.E. Maternal genetics effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 71 (2002) 1222-1226
21. Pfeiffer C.M., Huff D.L., and Gunter E.W. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45 (1999) 290-292
22. Miller A.S., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
23. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
24. van der Put N.M.J., Gabreëls F., Stevens B.E.M., Smeitink J.A.M., Trijbels F.J.M., Eskes T.K.A.B., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects?. Am J Hum Genet 62 (1998) 1044-1051
25. Leclerc D., Campeau E., Goyette P., Adjala C.E., Christensen B., Ross M., et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cbIG complementation group of folate/cobalamin disorders. Hum Mol Genet 5 (1996) 1867-1874
26. Tsai M.Y., Bignell M., Schwichtenberg K., and Hanson N.Q. High prevalence of a mutation in the cystathionine β-synthase gene. Am J Hum Genet 59 (1996) 1262-1267
27. Vilaseca M.A., Moyano D., Ferrer I., and Artuch R. Total homocysteine in pediatric patients. Clin Chem 43 (1997) 690-692
28. Green N.S. Folic acid supplementation and prevention of birth defects. J Nutr 132 (2002) 2356S-2360S
29. Alves-Silva J., Santos M.S., Guimarães P.E., Ferreira A.C.S., Bandelt H.S., Pena S.D.J., et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 67 (2000) 444-461
30. Steegers-Theunissen R.P., Boers G.H., Blom H.J., Nijhuis J.G., Thomas C.M.G., Borm G.F., et al. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172 (1995) 1436-1441
31. Malinow M.R., Rajkovic A., Duell P.B., Hess D.L., and Upson B.M. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism. Am J Obstet Gynecol 178 (1998) 228-233
32. Hobbs A.C., Cleves M.A., Melnyk S., Zhao W., and James S.J. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 81 (2005) 147-153
33. Shaw G.M., Zhu H., Lammer E.J., Yang W., and Finnell R.H. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 158 (2003) 747-752
34. van Rooji I.A.L.M., Swinkels D.W., Blom H.J., Merkus H.M.W.M., and Steegers-Theunissen R.P.M. Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am J Obstet Gynecol 189 (2003) 1155-1160
35. Arruda V.R., Siqueira L.H., Gonçalves M.S., von Zuben P.M., Soares M.C.P., Menezes R., et al. Prevalence of the mutation C677T in the methylenetetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78 (1998) 332-335
36. 12. BJOG 109 (2002) 784-791
37. Tsai M.Y., Yang F., Bignell M., Aras O., and Hanson N.Q. Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine β-synthase gene and pyridoxal-5′-phosphate concentration. Mol Genet Metab 67 (1999) 352-356